Cannabist Co. Holdings Aktie Logo
CA13765Y1034
A3EV8J
CBST.NE

Cannabist Co. Holdings Aktie

Cargando cotizaciones...

Previsión

Comprar
  1
Mantener
  0
Vender
  0

  • The Cannabist Company sells Virginia business to Curaleaf for $110 million

    The Cannabist Company is selling its cannabis business in Virginia to a Curaleaf subsidiary for $110 million ( $80 million in cash, $20 million deferred, $10 million Schuldschein bearing 6% interest). The deal includes five active retail locations, one in development, and roughly 82,000 square feet of cultivation and production space near Richmond, and substantially exceeds the company’s current market capitalization. A special committee is reviewing additional strategic options; part of the proceeds will be used to repay outstanding notes. Closing is expected in early 2026, subject to regulatory approvals and a 15-day go-shop period. » Más en de.investing.com


  • Cannabist Company reports revenue decline and falling EBITDA in Q3 2025

    Cannabist Company posted a 7.5% revenue decline to $80m in Q3 2025 and adjusted EBITDA fell from $8.5m to $3m. Wholesale revenue contracted sequentially by 20%. Despite the weakness, the company generated positive free cash flow of $2.3m and ended the quarter with $17.8m in cash. Management formed a special committee to review strategic alternatives including asset sales and mergers; at the same time the company exited Florida and sold three locations in Pennsylvania while opening two new shops in Ohio. » Más en de.investing.com


  • Cannabist Company reports revenue decline and share price loss due to restructuring

    Cannabist Company Holdings Inc. reported a slight revenue decrease to 87 million US dollars and a lower gross margin for the second quarter of 2025, as the company undergoes a comprehensive restructuring and withdraws from several markets. Despite an improved EBITDA margin and a focus on core markets, the share price fell by 8.79% following the announcement of the results. Management emphasized the priority of cost savings and operational efficiency, but continues to face risks such as market saturation and regulatory changes. » Más en de.investing.com

Datos financieros de la empresa

En el último trimestre, Cannabist Co. Holdings Aktie tuvo unos ingresos de 68,1 M € y un beneficio neto de -12,15 M €
(EUR) septiembre de 2025
YoY
Ingresos 68,1 M -
Beneficio bruto 19,52 M -
Beneficio neto -12,15 M -
EBITDA 6,65 M -

Datos fundamentales

Métrica Valor
Capitalización bursátil
12,92 M €
Número de acciones
497,46 M
Máximo/mínimo de 52 semanas
0,14 € - 0,0178 €
Dividendos No
Beta
1,05
Ratio P/E
-0,15
Ratio PEG
0,00
Ratio P/B
-0,10
Ratio P/S
0,09

Perfil de la empresa

The Cannabist Company Holdings Inc. se dedica al cultivo, la fabricación y la provisión de productos de cannabis y servicios relacionados en Estados Unidos y a nivel internacional. La empresa ofrece productos que abarcan flores, comestibles, aceites y tabletas bajo las marcas Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press y Amber. Posee licencias en 17 jurisdicciones de Estados Unidos. La empresa era conocida anteriormente como Columbia Care Inc. y cambió su nombre a The Cannabist Company Holdings Inc. en septiembre de 2023. La compañía fue fundada en 2012 y tiene su sede en Nueva York, Nueva York.

Nombre
Cannabist Co. Holdings Aktie
CEO
Christopher Marr
Sede Malvern, pa
Estados Unidos
Sitio web
Salida a bolsa
29/04/2019
Empleados 2829

Símbolos bursátiles

Bolsa Símbolo
Neo
CBST.NE
Pnk
CBSTF
Frankfurt
VW5.F
Düsseldorf
VW5.DU
München
VW5.MU
🍪

Parqet  usa cookies. Más información